Growth Metrics

LivaNova (LIVN) Divestments (2018 - 2021)

LivaNova recorded quarterly Divestments of -$43000.0 in Q2 2021, down 100.02% quarter-over-quarter from $173.4 million in Q2 2018.

LivaNova's Divestments history runs 2 years deep, the most recent figure standing at -$43000.0 for Q2 2021.

  • In Q2 2021, Divestments changed N/A year-over-year to -$43000.0; the TTM figure through Sep 2022 stood at -$43000.0 (changed 0.0% YoY), while the FY2021 annual figure was $23.1 million, changed N/A from the prior year.
  • Divestments came in at -$43000.0 for Q2 2021 at LivaNova, down from $173.4 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $173.4 million in Q2 2018 to a low of -$43000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 LivaNova 4.03 Bn 3.45 Bn 243.75 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 -43,000.00
Jun 30, 2018 173.38 Mn